This new indication allows individuals with or without symptoms to have access to this test without a prescription. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW COVID-19 Self Test for detection of COVID-19 infection. Centers for Disease Control and Prevention (CDC) guidelines, which is to communicate your results to your healthcare provider, who is responsible for reporting your test results to the state health department. Individuals who test positive are encouraged to follow the latest U.S. Individuals who test negative should continue to stay cautious, including following social distancing, hand washing and wearing a mask. The test can be used on children as young as two years old when samples are collected by an adult and for all people aged 15 years or older. Food and Drug Administration’s (FDA) serial (frequent) testing requirements for non-prescription, over-the-counter purchase.Īccording to the manufacturer’s instructions for use, people using the test should test themselves twice with at least 36 hours between tests. The Self Test is the identical format and technology as the professional test and will come in a two-count box to meet the U.S. The BinaxNOW COVID-19 Self Test is the most studied rapid antigen in the U.S., having first been approved in the U.S. “Together with vaccines and like-minded partners such as Walgreens, we can help people get back to doing what they love – like spending time with friends and family.”Ĭustomers can self-administer the test collection using a short nasal swab (not the deep and invasive nasopharyngeal swab) and check test results in 15 minutes. Wainer, executive vice president of Abbott’s rapid and molecular diagnostics business. “The BinaxNOW Self Test opens the door for Americans to buy an accurate and affordable test on their own terms, when and where they need it,” said Andrea F. This announcement builds upon Walgreens commitment to provide greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities. By May, Walgreens will expand testing to 6,000 drive-thru testing sites with half of these sites offering the no-cost, rapid Abbott ID NOW COVID-19 test. Walgreens has made significant strides to increase on-site COVID-19 testing capacity at more than 5,500 Walgreens pharmacies, with more than half of these locations located in socially vulnerable areas. “Working with Abbott and other partners, Walgreens now offers the most comprehensive suite of COVID-19 diagnostic testing options in America, helping encourage consistent, widespread testing.” The addition of this over-the-counter test in-store will help ensure our customers have access to testing solutions when and how they need it – at home or at one of our conveniently located testing sites,” said John Standley, president, Walgreens. “Even as vaccines become more widely available, COVID-19 testing remains a critical tool to keep our communities safe. This test will be available nationwide for $23.99 (MSRP). Beginning this week, this test will be available for purchase on, and later this week, it will be available for purchase in-store, for curbside pick-up, and same day delivery. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.Ībbott - A Leader in Rapid Point-of-Care Diagnostics.DEERFIELD, Ill., ApAs part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Abbott to sell the BinaxNOW™ Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide. Check with your local representative for availability in specific markets. Not all products are available in all regions. GDPR Statement | Declaration for California Compliance Law. Any person depicted in such photographs is a model. Photos displayed are for illustrative purposes only. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. This website is governed by applicable U.S. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |